Transrectal high-intensity focused ultrasound ablation of prostate cancer: Effective treatment requiring accurate imaging

European Journal of Radiology

Volumn 63, Issue 3, 2007, Pages 317-327

  Rouvière, Olivier ^a,b,c,d   Souchon, Rémi ^d   Salomir, Rarès ^d   Gelet, Albert ^a   Chapelon, Jean Yves ^d   Lyonnet, Denis ^a,b,c,d  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d INSERM   (France)

Author keywords

Color doppler; Contrast enhanced dynamic MRI; Elastography; HIFU ablation; Prostate cancer

Indexed keywords

PATIENT MONITORING; RADIOTHERAPY; REAL TIME SYSTEMS; TISSUE;

COLOR DOPPLER; CONTRAST-ENHANCED DYNAMIC MRI; ELASTOGRAPHY; HIFU ABLATION; PROSTATE CANCER;

ONCOLOGY;

ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; PATIENT MONITORING; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; SALVAGE THERAPY; TISSUE INJURY; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; RECTAL NEOPLASMS; SALVAGE THERAPY; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 34548266760     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2007.06.026     Document Type: Article

References (92)

1. Watkin N.A., ter Haar G.R., and Rivens I. The intensity dependence of the site of maximal energy deposition in focused ultrasound surgery. Ultrasound Med Biol 22 4 (1996) 483-491
2. Chapelon J.Y., Margonari J., Theillère Y., et al. Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog. Eur Urol 22 2 (1992) 147-152
3. Hill C.R., and ter Haar G.R. Review article: high intensity focused ultrasound-potential for cancer treatment. Br J Radiol 68 816 (1995) 1296-1303
4. Kennedy J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer 5 4 (2005) 321-327
5. Chapelon J.Y., Margonari J., Vernier F., et al. In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. Cancer Res 52 22 (1992) 6353-6357
6. Bataille N., Vallancien G., and Chopin D. Antitumoral local effect and metastatic risk of focused extracorporeal pyrotherapy on Dunning R-3327 tumors. Eur Urol 29 1 (1996) 72-77
7. Oosterhof G.O., Cornel E.B., Smits G.A., et al. Influence of high-intensity focused ultrasound on the development of metastases. Eur Urol 32 1 (1997) 91-95
8. Gelet A., Chapelon J.Y., Margonari J., et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 7 3 (1993) 249-253
9. Gelet A., Chapelon J.Y., Margonari J., et al. High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol 23 Suppl. 1 (1993) 44-47
10. Madersbacher S., Pedevilla M., Vingers L., et al. Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55 15 (1995) 3346-3351
11. Beerlage H.P., Thuroff S., Debruyne F.M., et al. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma. Urology 54 2 (1999) 273-277
12. Poissonnier L., Chapelon J.Y., Rouvière O., et al. Control of Prostate Cancer by Transrectal HIFU in 227 Patients. Eur Urol 51 2 (2007) 381-387
13. Uchida T., Ohkusa H., Yamashita H., et al. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer. Int J Urol 13 3 (2006) 228-233
14. Thuroff S., Chaussy C., Vallancien G., et al. High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. J Endourol 17 8 (2003) 673-677
15. Blana A., Walter B., Rogenhofer S., and Wieland W.F. High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience. Urology 63 2 (2004) 297-300
16. Chaussy C., Thuroff S., Rebillard X., and Gelet A. Technology insight: high-intensity focused ultrasound for urologic cancers. Nat Clin Pract Urol 2 4 (2005) 191-198
17. Chaussy C., and Thuroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 15 4 (2001) 437-440 discussion 47-8
18. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high intensity focused ultrasound for the treatment of localized prostate cancer: factors influencing the outcome. Eur Urol 40 2 (2001) 124-129
19. Gelet A., Chapelon J.Y., Bouvier R., et al. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer. J Endourol 14 6 (2000) 519-528
20. Rouvière O., Lyonnet D., Raudrant A., et al. MRI appearance of prostate following transrectal HIFU ablation of localized cancer. Eur Urol 40 3 (2001) 265-274
21. Uchida T., Ohkusa H., Nagata Y., et al. Treatment of localized prostate cancer using high-intensity focused ultrasound. BJU Int 97 1 (2006) 56-61
22. Thuroff S., and Chaussy C. High-intensity focused ultrasound: complications and adverse events. Mol Urol 4 3 (2000) 183-187 discussion 9
23. Chavrier F., Chapelon J.Y., Gelet A., and Cathignol D. Modeling of high-intensity focused ultrasound-induced lesions in the presence of cavitation bubbles. J Acoust Soc Am 108 1 (2000) 432-440
24. Vallancien G., Prapotnich D., Cathelineau X., et al. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 171 6 Pt 1 (2004) 2265-2267
25. Schellhammer P.F., Kuban D.A., and el-Mahdi A.M. Treatment of clinical local failure after radiation therapy for prostate carcinoma. J Urol 150 6 (1993) 1851-1855
26. Gelet A., Chapelon J.Y., Poissonnier L., et al. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography. Urology 63 4 (2004) 625-629
27. Partin A.W., Mangold L.A., Lamm D.M., et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 58 6 (2001) 843-848
28. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 5 (1999) 1499-1507
29. Abuzallouf S., Dayes I., and Lukka H. Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 171 6 Pt 1 (2004) 2122-2127
30. Horwitz E.M., Vicini F.A., Ziaja E.L., et al. The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys 41 2 (1998) 267-272
31. 18F-fluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 36 1 (2006) 73-92
32. Jana S., and Blaufox M.D. Nuclear medicine studies of the prostate, testes, and bladder. Semin Nucl Med 36 1 (2006) 51-72
33. Harisinghani M.G., Barentsz J., Hahn P.F., et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348 25 (2003) 2491-2499
34. Ghanem N., Uhl M., Brink I., et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55 1 (2005) 41-55
35. Bellin M.F., Beigelman C., and Precetti-Morel S. Iron oxide-enhanced MR lymphography: initial experience. Eur J Radiol 34 3 (2000) 257-264
36. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 44 1 (2003) 32-38 [discussion 8-9]
37. 18F]fluorodeoxyglucose-positron emission tomography. J Urol 169 4 (2003) 1337-1340
38. Heinisch M., Dirisamer A., Loidl W., et al. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?. Mol Imaging Biol 8 1 (2006) 43-48
39. Hovels A.M., Heesakkers R.A., Adang E.M., et al. Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CT. Eur Radiol 14 9 (2004) 1707-1712
40. Clements R. Ultrasonography of prostate cancer. Eur Radiol 11 11 (2001) 2119-2125
41. Kelly I.M., Lees W.R., and Rickards D. Prostate cancer and the role of color Doppler US. Radiology 189 1 (1993) 153-156
42. Rifkin M.D., Sudakoff G.S., and Alexander A.A. Prostate: techniques, results, and potential applications of color Doppler US scanning. Radiology 186 2 (1993) 509-513
43. Lavoipierre A.M., Snow R.M., Frydenberg M., et al. Prostatic cancer: role of color Doppler imaging in transrectal sonography. AJR Am J Roentgenol 171 1 (1998) 205-210
44. Kuligowska E., Barish M.A., Fenlon H.M., and Blake M. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers. Radiology 220 3 (2001) 757-764
45. Heijmink S.W., van Moerkerk H., Kiemeney L.A., et al. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol 16 4 (2006) 927-938
46. Frauscher F., Klauser A., Volgger H., et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167 4 (2002) 1648-1652
47. Unal D., Sedelaar J.P., Aarnink R.G., et al. Three-dimensional contrast-enhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 86 1 (2000) 58-64
48. Roy C., Buy X., Lang H., et al. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 170 1 (2003) 69-72
49. Halpern E.J., Rosenberg M., and Gomella L.G. Prostate cancer: contrast-enhanced us for detection. Radiology 219 1 (2001) 219-225
50. Pelzer A., Bektic J., Berger A.P., et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173 6 (2005) 1926-1929
51. Ives E.P., Gomella L.G., and Halpern E.J. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results. Radiology 237 1 (2005) 197-201
52. Jager G.J., Ruijter E.T., van de Kaa C.A., et al. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR Am J Roentgenol 166 4 (1996) 845-852
53. Quinn S.F., Franzini D.A., Demlow T.A., et al. MR imaging of prostate cancer with an endorectal surface coil technique: correlation with whole-mount specimens. Radiology 190 2 (1994) 323-327
54. Rouvière O., Hartman R.P., and Lyonnet D. Prostate MR imaging at high-field strength: evolution or revolution?. Eur Radiol 16 2 (2006) 276-284
55. Coakley F.V., Kurhanewicz J., Lu Y., et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology 223 1 (2002) 91-97
56. Scheidler J., Hricak H., Vigneron D.B., et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study. Radiology 213 2 (1999) 473-480
57. Zakian K.L., Sircar K., Hricak H., et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234 3 (2005) 804-814
58. Dhingsa R., Qayyum A., Coakley F.V., et al. Prostate cancer localization with endorectal MR imaging and MR spectroscopic imaging: effect of clinical data on reader accuracy. Radiology 230 1 (2004) 215-220
59. Rouvière O., Raudrant A., Ecochard R., et al. Characterization of time-enhancement curves of benign and malignant prostate tissue at dynamic MR imaging. Eur Radiol 13 5 (2003) 931-942
60. Engelbrecht M.R., Huisman H.J., Laheij R.J., et al. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging. Radiology 229 1 (2003) 248-254
61. Girouin N., Mège-Lechevallier F., Tonina Senés A., et al. Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?. Eur Radiol 17 6 (2007) 1498-1509
62. Oyen R.H. Dynamic contrast-enhanced MRI of the prostate: is this the way to proceed for characterization of prostatic carcinoma?. Eur Radiol 13 5 (2003) 921-924
63. Padhani A.R., Gapinski C.J., Macvicar D.A., et al. Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55 2 (2000) 99-109
64. Kiessling F., Lichy M., Grobholz R., et al. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI. Eur Radiol 14 10 (2004) 1793-1801
65. Buckley D.L., Roberts C., Parker G.J., et al. Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging-initial experience. Radiology 233 3 (2004) 709-715
66. Schlemmer H.P., Merkle J., Grobholz R., et al. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?. Eur Radiol 14 2 (2004) 309-317
67. Ogura K., Maekawa S., Okubo K., et al. Dynamic endorectal magnetic resonance imaging for local staging and detection of neurovascular bundle involvement of prostate cancer: correlation with histopathologic results. Urology 57 4 (2001) 721-726
68. Futterer J.J., Heijmink S.W., Scheenen T.W., et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 241 2 (2006) 449-458
69. Coakley F.V., Teh H.S., Qayyum A., et al. Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233 2 (2004) 441-448
70. Sala E., Eberhardt S.C., Akin O., et al. Endorectal MR imaging before salvage prostatectomy: tumor localization and staging. Radiology 238 1 (2006) 176-183
71. Rouvière O., Valette O., Grivolat S., et al. Recurrent prostate cancer after external beam radiotherapy: value of contrast-enhanced dynamic MRI in localizing intraprostatic tumor-correlation with biopsy findings. Urology 63 5 (2004) 922-927
72. Souchon R., Rouvière O., Gelet A., et al. Visualisation of HIFU lesions using elastography of the human prostate in vivo: preliminary results. Ultrasound Med Biol 29 7 (2003) 1007-1015
73. Gelet A., Chapelon J.Y., Bouvier R., et al. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. Eur Urol 29 2 (1996) 174-183
74. Sedelaar J.P., Aarnink R.G., van Leenders G.J., et al. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 37 5 (2000) 559-568
75. Curiel L., Souchon R., Rouvière O., et al. Elastography for the follow-up of high-intensity focused ultrasound prostate cancer treatment: initial comparison with MRI. Ultrasound Med Biol 31 11 (2005) 1461-1468
76. Hall T.J., Zhu Y., and Spalding C.S. In vivo real-time freehand palpation imaging. Ultrasound Med Biol 29 3 (2003) 427-435
77. Manduca A., Oliphant T.E., Dresner M.A., et al. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 5 4 (2001) 237-254
78. Muthupillai R., Lomas D.J., Rossman P.J., et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269 5232 (1995) 1854-1857
79. Rouvière O., Mège-Lechevallier F., Chapelon J.Y., et al. Evaluation of Color Doppler in guiding prostate biopsy after HIFU ablation. Eur Urol 50 3 (2006) 490-497
80. Eckersley R.J., Sedelaar J.P., Blomley M.J., et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 51 4 (2002) 256-267
81. Parivar F., Hricak H., Shinohara K., et al. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48 4 (1996) 594-599
82. Van den Berg C.A., Van de Kamer J.B., De Leeuw A.A., et al. Towards patient specific thermal modelling of the prostate. Phys Med Biol 51 4 (2006) 809-825 Epub 2006 Jan 25. Write to the Help Desk NCBI |NLM| NIH Department of Health & Human Services Privacy Statement |Freedom of Information Act| Disclaimer Aug 7 07:06:54
83. Xu L.X., Zhu L., and Holmes K.R. Thermoregulation in the canine prostate during transurethral microwave hyperthermia. Part II. Blood flow response. Int J Hyperthermia 14 1 (1998) 65-73
84. Chen L., ter Haar G., Hill C.R., et al. Effect of blood perfusion on the ablation of liver parenchyma with high-intensity focused ultrasound. Phys Med Biol 38 11 (1993) 1661-1673
85. Rouvière O., Curiel L., Chapelon J.Y., et al. Can color doppler predict the uniformity of HIFU-induced prostate tissue destruction?. Prostate 60 4 (2004) 289-297
86. Wiart M., Curiel L., Gelet A., et al. Influence of perfusion on high-intensity focused ultrasound prostate ablation: a first-pass MRI study. Magn Reson Med 58 (2007) 119-127
87. Uchida T., Illing R.O., Cathcart P.J., and Emberton M. The effect of neoadjuvant androgen suppression on prostate cancer-related outcomes after high-intensity focused ultrasound therapy. BJU Int 98 4 (2006) 770-772
88. Salomir R., Delamazure A.S., Palussière J., et al. Image-based control of the magnetic resonance imaging-guided focused ultrasound thermotherapy. Top Magn Reson Imaging 17 3 (2006) 139-151
89. Hindley J., Gedroyc W.M., Regan L., et al. MRI guidance of focused ultrasound therapy of uterine fibroids: early results. AJR Am J Roentgenol 183 6 (2004) 1713-1719
90. Ross A.B., Diederich C.J., Nau W.H., et al. Curvilinear transurethral ultrasound applicator for selective prostate thermal therapy. Med Phys 32 6 (2005) 1555-1565
91. Piel JE, Watkins RD, Gross P, et al. A transrectal focused ultrasound probe for MR-guided ablation of the prostate. Proceedings of the 13th Sientific meeting of the International Society for Magnetic Resonance in Medicine. Miami, 2005.
92. Paparel P., Curiel L., Chesnais S., et al. Synergistic inhibitory effect of high-intensity focused ultrasound combined with chemotherapy on Dunning adenocarcinoma. BJU Int 95 6 (2005) 881-885